期刊
DRUG DISCOVERY TODAY
卷 20, 期 2, 页码 267-276出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2014.10.002
关键词
-
资金
- National Science Foundation of China [21173156]
- National Basic Research Program of China (973 program) [2012CB932600]
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices
- Collaborative Innovation Center of Suzhou Nano Science and Technology
Farnesyltransferase (FTase) and geranylgeranyltransferase type I (GGTase-I) have crucial roles in the post-translational modifications of Ras proteins and, therefore, they are promising therapeutic targets for the treatment of various Ras-induced cancers and several other kinds of diseases. In this review, we provide an overview of the structures and biological functions of FTase and GGTase-I. Then, we summarize the typical inhibitors of FTase and GGTase-I, and highlight the drug candidates in clinical trials. In addition, we survey some recent advances in computer-aided drug design (CADD) and molecular modeling studies of FTase and GGTase-I.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据